New global trade association to advocate for the CNS industry.
More than 20 leading pharmaceutical, medical device, and diagnostic companies, along with major academic brain research centers and patient advocacy groups, have joined to form a new trade association called the Neurotechnology Industry Organization (NIO). Based in San Francisco, NIO is a nonprofit group created to accelerate the development of treatments and cures for central nervous system diseases.
“Despite the clear need and significant market opportunity, neurotechnology companies face a host of issues that stifle innovation, growth, and rapid delivery of effective therapies,” says Zack Lynch, founder and executive director of NIO. “NIO will provide a collective voice for commercial neuroscience organizations to address these issues.”
Founding member organizations include: Acumen Pharmaceuticals, Amarin, Brain Resource, Ceregene, Cyberkinetics Neurotechnology Systems, NeuroPace, NeuroNova, Sound Pharmaceuticals, Targacept, and United Therapeutics.
